[Fertility disorders of potentially curatively treated tumor patients. Consequences for the choice of primary therapy and after care].
The risk of therapy-induced fertility disorders is increasingly determining the choice of primary treatment, but also the form of follow-up care in young tumour patients. By using modified surgical procedures, differentiated radiotherapy and the preferential use of cytostatic agents with less influence on fertility, disturbances of fertility and sexual activity in tumour patients can often be avoided or at least reduced. In the after-care of tumour patients, measures for detecting and treating fertility disorders are becoming ever more important. The physicians delivering aftercare need to concern themselves with the organic and psychosocial problems arising from such disorders.
D000328:Adult; D000359:Aftercare; D000970:Antineoplastic Agents / Q000009:adverse effects; D001943:Breast Neoplasms / Q000628:therapy; D002369:Castration; D003131:Combined Modality Therapy; D005260:Female; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D007001:Hypogastric Plexus / Q000293:injuries; D007246:Infertility / Q000209:etiology*; D008197:Lymph Node Excision; D008297:Male; D008594:Menopause, Premature / Q000187:drug effects; D009369:Neoplasms / Q000628:therapy*; D011183:Postoperative Complications / Q000209:etiology; D011832:Radiation Injuries / Q000209:etiology; D011879:Radiotherapy Dosage; D013736:Testicular Neoplasms / Q000628:therapy; D002583:Uterine Cervical Neoplasms / Q000628:therapy
D000970:Antineoplastic Agents
Fertilitätsstörungen potentiell kurativ behandelter Tumorpatienten. Konsequenzen für die Wahl der Primärtherapie und die Nachsorge.